- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of January 2019
Here are the top 5 articles for the month of January.
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of January.
Number 5: The American Headache Society published an updated consensus statement outlining indications for initiating, continuing, combining, and switching migraine treatments. The statement included guidance on calcitonin gene-related peptide inhibitors, which entered the market last year.
Number 4: A study found that patients with a history of migraine are more likely to develop spontaneous coronary artery dissection at a younger age, have depression, and post-spontaneous coronary artery dissection chest pains compared with patients without a migraine history
Number 3: During the 37th Annual JP Morgan Healthcare Conference, FDA Commissioner Dr Scott Gottlieb offered details on the addition of a new office of drug development science that he said will bring more structure to the drug review process.
Number 2: A study in this month’s annual health information technology issue of AJMC found that for established patients, virtual video visits may provide effective follow-up and enhanced convenience when compared with traditional office visits.
Number 1: Following the JP Morgan Healthcare Conference, we rounded up the top 5 things to know from the conference, including its focus on digital health, acquisition, and more.
To read all of these articles and more, visit ajmc.com.
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
CGRP Inhibitors: A Promising New Class of Drugs for Migraine
November 14th 2018This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.
Listen
